Overview

Nazia Khan is an associate in the Corporate Practice Group in the firm's Dallas office.

Areas of Practice

Nazia’s practice focuses on corporate finance and securities laws. She represents companies and underwriters in public and private corporate finance transactions, including initial public offerings, shelf registrations, registered direct transactions, private investments in public equity (PIPEs), private placements and other securities offerings.

In addition, Nazia represents publicly held companies with their reporting obligations under the Exchange Act and with NASDAQ, NYSE and other exchange listing and compliance matters including matters involving FINRA.

Experience

Experience

  • Represented Hoth Therapeutics, Inc. in its initial public offering and listing on Nasdaq
  • Represented Immuron Limited in its initial public offering and listing on Nasdaq
  • Represented Aridis Pharmaceuticals, Inc., in its initial public offering and listing on Nasdaq
  • Represented underwriters in an initial public offering and listing on Nasdaq of a company in the rideshare industry
  • Represented underwriters in an initial public offering of and listing on Nasdaq of a biotechnology company focused on early cancer screening and detection

Honors

Honors

New York Metro Rising Stars, Super Lawyers, 2017-2019

Who's Who in America, 2019

Insights

Media Mentions

Education

J.D., California Western School of Law, 2013, with honors

B.S., George Mason University, 2010, cum laude

Admissions

  • Texas
  • New York
  • New Jersey

Languages

Jump to Page

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.